semaglutide and trevogrumab Combinations Show Promise in Phase 2 COURAGE Obesity Trial Biotech Watchlist: Trevogrumab, A New
Description
Not surprisingly given the classification criteria, body fat percentage (MannWhitney test, P 40% overweight) based on body composition analysis by DXA, and then to compare differences in weight loss outcomes between classes
Key difference from GLP-1s: Doesn't suppress appetite
Each vial contains 5mg of highly pure TB-500
Polyphenols combat oxidative stress and inflammation by neutralizing reactive oxygens species (7, 8)
